您的购物车当前为空
别名 EPZ-6438 trihydrochloride, E-7438 trihydrochloride
Tazemetostat trihydrochloride is a selective and orally available inhibitor of EZH2 (IC50: 4 nM for rat EZH2). It inhibits the activity of human PRC2-containing wild-type EZH2 (Ki: 2.5 nM). It inhibits EZH2 (IC50s: 11 and 16 nM in peptide assay and nucleosome assay).

Tazemetostat trihydrochloride is a selective and orally available inhibitor of EZH2 (IC50: 4 nM for rat EZH2). It inhibits the activity of human PRC2-containing wild-type EZH2 (Ki: 2.5 nM). It inhibits EZH2 (IC50s: 11 and 16 nM in peptide assay and nucleosome assay).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 11,350 | 2-4周 | |
| 50 mg | ¥ 15,300 | 2-4周 | |
| 100 mg | ¥ 19,000 | 2-4周 |
Tazemetostat trihydrochloride 相关产品
| 产品描述 | Tazemetostat trihydrochloride is a selective and orally available inhibitor of EZH2 (IC50: 4 nM for rat EZH2). It inhibits the activity of human PRC2-containing wild-type EZH2 (Ki: 2.5 nM). It inhibits EZH2 (IC50s: 11 and 16 nM in peptide assay and nucleosome assay). |
| 靶点活性 | EZH2 (WT):2.5 nM (ki), EZH2 (rat):4 nM, EZH2:11 nM (in peptide assay), EZH2:16 nM (in nucleosome assay), EZH1:392 nM |
| 体外活性 | Tazemetostat inhibits multi wild-type and mutant lymphoma cell lines proliferation (IC50s: 0.49 nM-7.6 μM). |
| 体内活性 | Tazemetostat (250 or 500 mg/kg twice daily for 21-28 days) almost removes the fast-growing G401 tumors. |
| 别名 | EPZ-6438 trihydrochloride, E-7438 trihydrochloride |
| 分子量 | 682.12 |
| 分子式 | C34H47Cl3N4O4 |
| CAS No. | 1403255-00-4 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容